Salvatore Girardo Cardiologists is categorized under Internal Medicine Doctors in Philadelphia, PA and active since 1975.
Salvatore Girardo Cardiologists was established in 1975, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Salvatore Girardo at the company’s single location by writing to 1317 Wolf St, Philadelphia, Pennsylvania PA 19148 or by phoning (215) 389-0700. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Salvatore Girardo Cardiologists |
Contact Person: | Salvatore Girardo |
Address: | 1317 Wolf St, Philadelphia, Pennsylvania 19148 |
Phone Number: | (215) 389-0700 |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 1975 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Internal Medicine Doctors |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Salvatore Girardo Cardiologists was started in 1975 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Salvatore Girardo for inquiries that concern Salvatore Girardo Cardiologists by calling the company number (215) 389-0700, as your correspondence is most welcome. Additionally, the physical location of the single location of Salvatore Girardo Cardiologists can be found at the coordinates 39.921849,-75.168835 as well as the street address 1317 Wolf St in Philadelphia, Pennsylvania 19148.
For its online presence, you may visit Salvatore Girardo Cardiologists’s website at and engage with its social media outlets through on Twitter and on Facebook.